Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could VR worlds sharpen the aging mind? a new trial puts it to the test

NCT ID NCT07033468

Symptom relief Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study tests whether fully immersive virtual reality (VR) cognitive training can improve thinking skills in people with mild to moderate dementia. Participants will either start VR training right away or after a waiting period, allowing a comparison. The trial measures changes in memory, attention, daily living activities, and quality of life over 15 sessions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Fully immersive virtual reality cognitive training sessions
What this could lead to
If effective, this could offer an engaging, non-drug way to support cognitive function and quality of life for people living with dementia.
What could go wrong
This is an early feasibility study with a small number of participants, so results may not apply broadly. VR may cause discomfort or be difficult for some people with dementia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age over 55 years; 2. Diagnosed with mild or moderate dementia (primarily degenerative dementia) by a consulting physician or based on past medical records; 3. A score of at least 11 but no more than 23 on the Mini-Mental State Examination (MMSE); 4. Has at least one family member or a regularly contacted friend (with the person's mobile number and contact at least once a week); 5. Able to walk independently and complete the Timed Up \& Go (TUG) test; 6. Able to follow instructions with or without the assistance of a guardian or therapist; 7. If the assessment indicates moderate dementia, further evaluation will be conducted to determine whether the participant has sufficient capacity to provide informed consent. If their capacity is found to be impaired, the study will be explained to their legal representative Exclusion Criteria: 1. Dementia with Lewy Bodies and other dementia types resulting from specific causes, such as Huntington's Disease, substance addiction, central nervous system infections, nutritional deficiencies, and metabolic disorders. 2. Severe health conditions that may hinder safe participation, such as respiratory distress, severe cardiovascular disease, or brain tumors. 3. A psychiatric diagnosis of psychosis within the past six months. 4. Diagnosis of Korsakoff syndrome. 5. History of substance addiction. 6. Severe hearing impairment or color blindness. 7. History of severe vertigo or epilepsy. 8. Concurrent participation in other studies that may affect cognitive function

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mild to moderate dementia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mild to moderate dementia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tucheng Hospital, New Taipei City, commissioned and operated by Chang Gung Medical Foundation.

    RECRUITING

    New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.